Suzanne King
Psychiatry · Saint Louis, MONPI 1760469977
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 70.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $15,082 and has fallen 95.4% since, to $700 in 2025. Among psychiatry clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $76.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$15K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Neurocrine Biosciences, Inc.$1K
- Alkermes, Inc.$1K
- Sunovion Pharmaceuticals Inc.$974
- Otsuka America Pharmaceutical, Inc.$694
- plus $1K from 9 others
What the payments were for
- Speaking & faculty fees$11,20053%
- Travel & lodging$2,77513%
- Food & beverage$7,15734%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $14,915 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 55 | $1,110 |
| Neurocrine Biosciences, Inc. | 31 | $1,102 |
| Alkermes, Inc. | 30 | $1,009 |
| Sunovion Pharmaceuticals Inc. | 52 | $974 |
| Otsuka America Pharmaceutical, Inc. | 11 | $694 |
| Axsome Therapeutics, Inc. | 10 | $558 |
| Lundbeck LLC | 8 | $174 |
| Teva Pharmaceuticals USA, Inc. | 5 | $156 |
| Ironshore Pharmaceuticals Inc. | 2 | $107 |
| Jazz Pharmaceuticals Inc. | 1 | $107 |
| Corium, LLC | 1 | $104 |
| Johnson & Johnson | 6 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $22 |
| Neuronetics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$13,843
- LYBALVI$889
- INGREZZA$476
- Auvelity$327
- ABILIFY ASIMTUFII$309
- ABILIFY MAINTENA$309
- SUNOSI$107
- UZEDY$106
- REXULTI$104
- Azstarys$104
How this compares
$21,144 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 16 | $128,466 |
| VraylarCariprazine Hcl | 36 | $61,634 |
| Lurasidone Hcl | 46 | $2,125 |
| Risperidone | 89 | $833 |
| Quetiapine Fumarate | 67 | $620 |
| Olanzapine | 29 | $609 |
| Aripiprazole | 12 | $394 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $330 |
| Duloxetine Hcl | 25 | $285 |
| Lamotrigine | 19 | $252 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $243 |
| Buspirone Hcl | 41 | $242 |
| Trazodone Hcl | 44 | $236 |
| Hydroxyzine Hcl | 22 | $217 |
| Mirtazapine | 11 | $206 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,102 | $128,46616 claims |
| AbbVieVraylar | $14,915 | $61,63436 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Saint Louis
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
- George GrossbergSaint Louis$501K
- Christopher LoyndSaint Louis$265K
- Devnandini RastogiSaint Louis$261K
- Michael StotlerSaint Louis$250K
- James ChoSaint Louis$118K
- Steven HarveySaint Louis$90K
- Kevin BlackSaint Louis$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.